Status:
UNKNOWN
Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
Lead Sponsor:
University of Liege
Collaborating Sponsors:
EGID, Lille
Conditions:
Diabete Type 2
Eligibility:
All Genders
18+ years
Brief Summary
Single-center trial The goal is to better understand the various genetic mutations encountered in cases of type 2 diabetes as well as their frequency of occurrence in the population. Such analyzes al...
Detailed Description
Procedure and methodology: during a follow-up visit to their usual diabetist (at CHU de Liège), we will send each potential volunteer, fulfilling the conditions for inclusion, an information and conse...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- diabetes type 2
- Criteria exclusion:
- Refusal of participation
- Type 1 diabetic
- Presence of auto-antibodies directed against the β cells of the pancreas (insulin-secreting)
Exclusion
Key Trial Info
Start Date :
September 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04700813
Start Date
September 13 2019
End Date
September 30 2021
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marjorie Fadeur
Liège, Belgium, 4000